Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

6.63
Delayed Data
As of Dec 07
 -0.25 / -3.63%
Today’s Change
6.22
Today|||52-Week Range
14.50
-33.03%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close6.88
Today’s open6.81
Day’s range6.54 - 6.95
Volume1,794,251
Average volume (3 months)1,317,931
Market cap$568.9M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-34.26%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+4.08%
P/E ratioNM
Price/Sales4.36
Price/Book4.53

Competitors

 Today’s
change
Today’s
% change
BEATBioTelemetry Inc-0.15-0.73%
CRYCryoLife Inc+0.05+0.28%
MZORMazor Robotics Ltd-0.36-1.61%
CERSCerus Corp-0.11-2.17%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$153.6M
Annual profit (last year)-$50.4M
Net profit margin-32.83%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs